Navigation Links
Global CRISPR Market 2015-2021: New Technology is Driving Growth
Date:1/18/2016

DUBLIN, January 18, 2016 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/n33bc6/global_crispr) has announced the addition of the "Global CRISPR Market 2015 - 2021" report to their offering. 

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The Global CRISPR Market is driven by high demand for plasmids, synthetic genes and high quality gene slicing techniques. Growing drug discovery, biotechnology and proteomics markets are also driving the market growth.

The market is expected to grow at a CAGR of 43% from 2015 to 2021. This is driven by the fact that CRISPR is a new technology which is simple, more efficient and cost effective as compared to its peers. High adoption both in biotech and pharma industry along with high level of research is also responsible for high growth rate. 

The market for CRISPR technology is niche. The number of companies are still very less and most of the companies are start-ups which are going through rounds of funding. 

Most of the companies are relying on the disruptive nature of the technology. CRISPR has the capability to open new markets for gene surgery and genetically modified organisms. However, there are major concerns from the scientific community regarding the misuse of such technology in human cloning. Geographically North America leads the market race followed by Europe and Asia Pacific. 

Companies Mentioned: 

  • Thermo Fisher Scientific
  • Editas Medicine
  • Caribou Biosciences
  • CRISPR therapeutics
  • Intellia
  • Cellectis
  • Horizon discovery PLC
  • Sigma Aldrich
  • Precision biosciences
  • GenScript
  • Sangamo Biosciences Inc.
  • Lonza group limited
  • Integrated DNA technologies
  • New England Biolabs
  • Oregene Technologies
  • Transposgen Biopharmaceuticals

Key Topics Covered: 

1. Executive Summary

2. Market Overview 

3. Sector Analysis 

4. Market Determinants

5. Market Segmentation 

6. Geographical Analysis 

7. Company Profiling 

For more information visit http://www.researchandmarkets.com/research/n33bc6/global_crispr


About Research and Markets: 

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Laura Wood
+353-1-481-1716
press@researchandmarkets.net



'/>"/>
SOURCE Research and Markets
Copyright©2016 PR Newswire.
All rights reserved


Related biology technology :

1. Analyzing the Global Biotechnology Industry 2015
2. Global Genitourinary Partnering 2010-2016: Deal trends, players and financials
3. The Human Vaccines Project Welcomes Sanofi Pasteur to Its Global Consortium
4. Global Anaerobic Digestion (AD) Market 2016-2026
5. ConferenceSeries.com : The Ultimate Destination to Connect Global Experts and B2B Meetings
6. BSI and ACRES Developing Global Accreditation Standards for Clinical Research Sites
7. Global Human Reproductive Technologie Industry
8. Global Genomics Company, GENEWIZ, Receives Investment
9. Global E-Clinical Solution Market Expected to Grow With 14% CAGR During 2015 - 2020
10. P&S Market Research
11. Orexigen Therapeutics to Speak at the J.P. Morgan 2016 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2020)... Ore. (PRWEB) , ... August 13, 2020 , ... ... the creation of its Scientific Advisory Board (SAB) to research the medical potential ... cannabis can be enhanced when combined with terpenes. The board is focused on expanding ...
(Date:8/12/2020)... ... August 12, 2020 , ... Inc. ... a global leader in FDA compliance consulting has been named on its annual ... The list represents a unique look at the most successful companies within the ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is now ... With 50 million stem cells total, patients may choose which extremities they would like ... arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is obtained ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, ... have entered into a strategic partnership whereby Catalent will provide support for the ...
Breaking Biology Technology:
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. ... Neihulizumab, a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at ... Paul J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label ...
(Date:7/1/2020)... (PRWEB) , ... July 01, 2020 , ... ... that it had completed the purchase of Teva-Takeda Pharmaceuticals’ packaging facility in Minakuchi, ... company’s existing Japanese clinical supply facility located in Kakegawa, the new 60,000-square-foot facility ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... for biopharmaceutical R&D, today announced that it has entered into a multi-year ... antibodies (Multiclonics®), to support their translational and clinical research strategy to discover ...
Breaking Biology News(10 mins):